March 2025

Breaking News: FDA announces new recall of Medtronic surgical devices ()
TAVR vs. SAVR after 5 years in low-risk patients | Semaglutide & PAD | Nasal spray not approved | GE HealthCare's new CT scanner ()
Week in Review: Recall update | New drug shows potential to treat AS | Medicare coverage for TTVR | TAVR data at ACC.25 ()
A message for RFK Jr. about the state of cardiology | Strokes & heart transplants | A key approval for Abbott's PFA system ()
FDA sees promise in AI model | Working to locate more AS patients | OJ & heart health | Timing is everything ()
One way AI can help cardiologists | FDA announces catheter recall due to stroke risk | Wearable tech company to go public ()
New TAVR data coming to ACC.25 | Statin therapy & pregnancy | 5-year data on first-in-class SAVR valve ()
New drug could limit need for TAVR, SAVR | Key tricuspid valve trends | FDA OKs another ATTR-CM therapy | Abbott's IVL move ()
How to address burnout | CMS approves coverage for TTVR | Devices recalled over safety concerns | Does marketing to docs work? ()
Week in Review: Cannabis use in young adults | TAVR or TAVI? | AI’s growing role | Cath lab radiation | Generics of rivaroxaban ()
AI highlights key heart findings in mammograms | TAVR for failing surgical valves | Radiation exposure in the cath lab ()
Advances in bioresorbable stents | Cannabis use in young adults | Mitral valve repair vs. replacement for infective endocarditis ()
AI in cardiovascular imaging & interventional cardiology | FDA OKs generic versions of rivaroxaban | Bracco updates HeartSee ()
New cardiogenic shock guidelines | Misdiagnosis at heart of wrongful death lawsuit | 5-year data on Abbott's Amulet ()
TAVR or TAVI? Cardiology groups urged to agree | AI predicts bleeding, stroke risks | Food insecurity & heart disease ()
Week in Review: TAVR outperforms SAVR | Family files lawsuit after transplant ends in death | Trends in diagnostic heart testing ()
Key trends in diagnostic heart testing | Patient discharged with total artificial heart for first time | TAVR data out of Africa ()
New heart failure data show progress | Comparing 2 FDA-approved stroke drugs | Doctor accused of sexually assaulting colleagues ()
FDA clears new CCTA software for plaque evaluations | Family files lawsuit after heart transplant ends in tragedy ()
TAVR bests SAVR in terms of valve performance | Cardiology groups urge Congress to ‘take a stand’ | Updated SMART data ()
SCAI works to improve cath lab protection | Early AVR for asymptomatic severe AS boosts outcomes | New ASE guidelines ()
Week in Review: PFA catheters recalled | Devices pulled from market | FDA approves stroke drug | New ACS guidelines ()
The world’s first robotic transcatheter mitral valve replacements | Tiny pacemakers for infants | Building a CCTA program ()
FDA approves new stroke drug | First-in-human data on TAVR catheter from Boston Scientific | Surgical valve updates approved ()
AI & CCTA make an impact | TAVR vs. SAVR | Doctors start using FDA-cleared heart device | Shockwave launches new IVL catheter ()
February's Top Stories: Devices breaking during use | Pacemakers recalled | The most lucrative heart procedures for hospitals ()
Philips pulls medical devices over safety concerns | Boston Scientific enters renal denervation market | New ACS guidelines ()
PFA catheters recalled | Surgeons make history | Request for an American Board of Cardiovascular Medicine denied | CCTA adoption ()
Week in Review: Pacemakers recalled | FDA ends semaglutide shortage | Researchers target Lp(a) | Comparing popular TAVR valves ()